Skip to content
healthcare.dev

VORICONAZOLE

NDC 14335-730, VORICONAZOLE, injection, solution, from Hainan Poly Pharm. Co., Ltd..

Product NDC
14335-730
Status
Listed
Labeler
Hainan Poly Pharm. Co., Ltd.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA220043
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/14335-730 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VORICONAZOLE10 mg/mL

Pharmacologic classes

Azole Antifungal [EPC]; Azoles [CS]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]

Package NDCNDC-11Package
14335-730-10143350730101 VIAL, SINGLE-USE in 1 CARTON (14335-730-10) / 20 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/393a81ba-7d51-450e-8d20-23287767c002

Use it

Look up 14335-730 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/14335-730 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 14335-730. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.